Molecular testing for HNPCC can be performed by testing tumours for MSI and absence of MLH1, PMS2, MSH2 and/or MSH6 as determined by immunohistochemistry (IHC), and germline mutation analysis of MMR genes. This evidence concerns the gene MSH6 and neoplasm.